Monoclonal
Monoclonal Antibody Reduces Asthma Attacks in Black and Latino Youth
A National Institutes of Health (NIH) clinical trial found that mepolizumab, a monoclonal antibody, decreased asthma attacks by 27% among Black and...
NIH launches trial of monoclonal antibody to treat asthma in urban youth
Study also will examine relationship of airway gene network activity to health outcomes.
Dupilumab is approved by the U.S. Food and Drug Administra...
A High-Risk Patient With COVID-19 Vaccine Hesitancy Successfully Treated With Monoclonal Antibodies Through Two Major Surges
Case Reports
. 2022 Feb 28;14(2):e22721.
doi: 10.7759/cureus.22721.
eCollection 2022 Feb.
Affiliat...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
